Treating Parkinsonís Disease with Targeted Therapeutic Vaccines

Share

(January 5, 2015) – EU funded researchers are about to begin clinical trials on a new Parkinson’s disease vaccine that may be able to modify disease progression, rather than simply providing symptomatic improvement. The new vaccine works by targeting a specific protein called alpha-Synuclein. Read more…

Click for a printer friendly version

Back to top